1061 related articles for article (PubMed ID: 16870827)
1. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
Mehta PK; Griendling KK
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C82-97. PubMed ID: 16870827
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-triggered kinase signaling cascade in the central nervous system.
Bali A; Jaggi AS
Rev Neurosci; 2016 Apr; 27(3):301-15. PubMed ID: 26574890
[TBL] [Abstract][Full Text] [Related]
3. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in angiotensin II signaling.
Touyz RM; Berry C
Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172
[TBL] [Abstract][Full Text] [Related]
5. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
Hunyady L; Catt KJ
Mol Endocrinol; 2006 May; 20(5):953-70. PubMed ID: 16141358
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.
Touyz RM
Braz J Med Biol Res; 2004 Aug; 37(8):1263-73. PubMed ID: 15273829
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II and vascular injury.
Montezano AC; Nguyen Dinh Cat A; Rios FJ; Touyz RM
Curr Hypertens Rep; 2014 Jun; 16(6):431. PubMed ID: 24760441
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
Weir MR; Dzau VJ
Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
[TBL] [Abstract][Full Text] [Related]
10. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle.
Rocic P; Govindarajan G; Sabri A; Lucchesi PA
Am J Physiol Cell Physiol; 2001 Jan; 280(1):C90-9. PubMed ID: 11121380
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and the vascular phenotype in hypertension.
Savoia C; Burger D; Nishigaki N; Montezano A; Touyz RM
Expert Rev Mol Med; 2011 Mar; 13():e11. PubMed ID: 21450123
[TBL] [Abstract][Full Text] [Related]
13. Signaling mechanisms of angiotensin II in regulating vascular senescence.
Min LJ; Mogi M; Iwai M; Horiuchi M
Ageing Res Rev; 2009 Apr; 8(2):113-21. PubMed ID: 19162241
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II mediated signal transduction. Important role of tyrosine kinases.
Haendeler J; Berk BC
Regul Pept; 2000 Nov; 95(1-3):1-7. PubMed ID: 11062326
[TBL] [Abstract][Full Text] [Related]
15. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
[TBL] [Abstract][Full Text] [Related]
17. Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells.
Meloche S; Pelletier S; Servant MJ
Mol Cell Biochem; 2000 Sep; 212(1-2):99-109. PubMed ID: 11108141
[TBL] [Abstract][Full Text] [Related]
18. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 and type 2 receptor-induced cell signaling.
Akazawa H; Yano M; Yabumoto C; Kudo-Sakamoto Y; Komuro I
Curr Pharm Des; 2013; 19(17):2988-95. PubMed ID: 23176210
[TBL] [Abstract][Full Text] [Related]
20. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
